Ir a las Transacciones
Salud

Clínica Las Condes has completed a successful bond voluntary call option

Clínica Las Condes has completed a bond voluntary call option with the goal of reducing financial debt and interest expenses.

Based in Santiago, Chile, Clínica Las Condes is one of the largest private hospitals in the country. It initiated its operations in 1982, with a focus in high complexity medicine. Its services include inpatient medical, surgical intensive care units, intermediate, adult, pediatric, neonatal, surgical wards, post-recovery operative, clinical laboratories, radiology, CT magnetic resonance imaging, radiation therapy, PET-CT, nuclear medicine, ultrasound, dialysis and other services that include outpatient procedures.

Oaklins’ team in Chile acted as financial advisor to Clínica Las Condes.

Contáctese con el equipo de la transacción

Sebastián Cereceda

Socio
Santiago, Chile
Oaklins LarrainVial

Transacciones relacionadas

Leika Medical Equipments Ltd. has been acquired by Angus Capital
Private Equity | Salud

Leika Medical Equipments Ltd. has been acquired by Angus Capital

The shareholders of Leika Medical Equipments Ltd. have sold the company to Angus Capital.

Aprenda más
Phen’X Technologies has sold a majority stake to Ciclad
Private Equity | Salud | Maquinaria y Componentes Industriales

Phen’X Technologies has sold a majority stake to Ciclad

The shareholders of Phen’X Technologies have completed a primary majority LBO with private equity fund Ciclad.

Aprenda más
Medis Medical Imaging and GE HealthCare announce collaboration focused on non-invasive coronary assessments
Salud | TMT

Medis Medical Imaging and GE HealthCare announce collaboration focused on non-invasive coronary assessments

Medis Medical Imaging Systems B.V., a leading cardiac imaging software company, have completed a strategic investment to further develop its revolutionary non-invasive cardiovascular imaging solution. The company has announced its collaboration with GE HealthCare (Nasdaq: GEHC), a global leader in medical technology, pharmaceutical diagnostics and innovation in digital solutions, to contribute to the advancement of precision care in the diagnosis and treatment of coronary artery disease (CAD).

Aprenda más